The AMD Center

Filter Your Results




Drug Selection and Patient Outcomes in AMD

David Eichenbaum, MD, demonstrates how drug selection can affect outcomes over time by sharing the cases of two patients…

David Eichenbaum, MD

Potential Treatments for AMD

Thomas Ciulla, MD, describes a study designed to address an unmet need in AMD. Anti-VEGF therapy is very effective in th…

Thomas Ciulla, MD

Drug Delivery to the Posterior Segment

At a Glance • Intravitreal injection is the current drug delivery method of choice. • Topical drug deliv…

Daniel D. Esmaili, MD; and David S. Boyer, MD

Examining the Systemic Safety of Anti-VEGF Agents

At a Glance • Anti-VEGF agents can enter the circulation and reduce systemic VEGF levels. • Fellow-eye e…

Karen Roman, Editor-in-Chief

A Dual-Mechanism Drug for Vitreoretinal Diseases

At a Glance • Integrins are cell surface receptors involved in angiogenesis and inflammation. • Although…

Baruch D. Kuppermann, MD, PhD

Profile of a Potential Treatment for Geographic Atrophy

At a Glance • GA significantly impairs patients’ visual function and quality of life. • Lampalizum…

Karen Roman, Editor-in-Chief

Another Anti-VEGF Agent for Treatment of Neovascular AMD

At a Glance • The chemical composition of conbercept, an anti-VEGF agent approved in China, may give it added …

Xiaoxin Li, MD, PhD; Xiaoyan Ding, MD, PhD; and Peter K. Kaiser, MD

Long-Lasting Effects of Combination Anti-VEGF and Photodynam…

At a Glance • Despite the low complication rate associated with anti-VEGF injections, they can contribute to…

Kent W. Small, MD; Fadi Shaya, BS; Rosemary Silva-Garcia, MD; and Colleen McLellan, BS


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.